Variability in aflatoxin B1-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver

Toxicology and Applied Pharmacology

Volumn 181, Issue 1, 2002, Pages 48-59

  Doi, Adriana M ^a   Patterson, Paula E ^a   Gallagher, Evan P ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aflatoxin B1; Biotransformation; Human liver; Macromolecular adducts; Ontogeny

Indexed keywords

AFLATOXIN B1; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; DNA; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; LIPOXYGENASE; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DNA ADDUCT; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; FETUS; HUMAN; HUMAN TISSUE; LIVER TOXICITY; MACROMOLECULE; MALE; PROTEIN BINDING; SECOND TRIMESTER PREGNANCY;

SIGANUS;

EID: 0037094748     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2002.9399     Document Type: Article

References (92)

1. Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype
2. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1
3. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver: cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine
4. Transplacental transfer of genotoxins and transplacental carcinogenesis
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. Risk assessment for aflatoxin. II. Implications of human epidemiology data
7. Aflatoxins
8. Primary cancer of the liver in Kenyan children
9. Epidemiologic characteristics of malignant neoplasms in Taiwan. I. All cancer sites
10. 1-induced cytotoxicity and inhibition of RNA synthesis in isolated rat hepatocytes
11. Metabolism of cyclosporin A. IV. Purification and identification of the Rifampicin-inducible human liver cytochrome P450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily
12. Onset of xenobiotic metabolism in children: Toxicological implications
13. Peroxidative xenobiotic oxidation by partially purified peroxidase and lipoxygenase from human fetal tissues at 10 weeks of gestation
14. 1 by lipoxygenase purified from human term placenta and intrauterine conceptal tissues
15. Cytochrome P450 3A: Ontogeny and drug disposition
16. 1 in cultured mouse hepatocytes: Comparison with rat and effects of cyclohexene oxide and diethyl maleate
17. Transplacental transfer of aflatoxin in humans
18. 1 in human lung
19. Mechanisms of aflatoxin carcinogenesis
20. Role of cytochrome P4501A2 in chemical carcinogenesis: Implications for human variability in expression and enzyme activity
21. 1 defines a subfamily of aldo-keto reductases
22. Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue
23. 1 metabolism in human liver
24. 1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4
25. 1
26. 1 on pregnant inbred Sprague-Dawley rats and their F1 generation: A contribution to transplacental carcinogenesis
27. The carcinogenic potential of aflatoxin or its metabolites in rats from dams fed aflatoxin pre- and postpartum
28. Molecular dosimetry methods for assessing human aflatoxin exposure
29. Aflatoxins as risk factors for liver cancer: An application of monoclonal antibodies to monitor human exposure
30. Aflatoxin exposure in human populations: Measurements and relationship to cancer
31. 1
32. 1 and relevance to risk of human liver cancer
33. Human hepatic microsomal epoxide hydrolase: Comparative analysis of polymorphic expression
34. 1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin
35. 1-DNA adducts in human placenta and cord blood
36. Multiple forms of human P450 expressed in Saccharomyces cerevisiae: Systematic characterization and comparison with those of the rat
37. 1-aldehyde reductase
38. 1 exo-8,9-epoxide catalyzed by rat and human glutathione transferases: Estimation of kinetic parameters
39. 1 8,9-epoxide hydrolysis in the presence of rat and human epoxide hydrolase
40. Xenobiotic biotransformation/bioactivation in organogenesis-stage conceptal tissues: Implications for embryotoxicity and teratogenesis
41. Purification from rat liver of a novel constitutively expressed member of the aldo-keto reductase 7 family that is widely distributed in extrahepatic tissues
42. Cytochrome P450 in human fetal liver: Significance and fetal-specific expression
43. Purification and properties of cytochrome P-450 from homogenates of human fetal livers
44. 1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3
45. Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450
46. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
47. Expression of CYP3A in the human liver: Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth
48. Glutathione S-transferase μ in human lymphocyte and liver: Role in modulating formation of carcinogen-derived DNA adducts
49. 1
50. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism
51. 1 to DNA in the mouse
52. 1 in human-derived in vitro systems
53. In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam
54. Developmental expression of human microsomal epoxide hydrolase
55. Glutathione S-transferase in humans: Development and tissue distribution
56. Epoxide hydrolase in human fetal liver
57. Covalent binding of electrophilic metabolites to macromolecules
58. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China
59. 1
60. 1 biotransformation in vitro and DNA binding in vivo by dietary broccoli in rats
61. 1 by human liver microsomes: Role of cytochrome P450 IIIA enzymes
62. 1 exo- and endo-epoxides by rat and human glutathione S-transferases
63. Effects of liver disease on pharmacokinetics: An update
64. Biochemical mechanisms and biological implications of the toxicity of aflatoxins as related to aflatoxin carcinogenesis
65. Isolation and some properties of dioxygenase and co-oxidase activities of adult human liver cytosolic lipoxygenase
66. 1 epoxidation catalysed by partially purified human liver lipoxygenase
67. Conversion of arachidonic acid to lipoxygenase products by human fetal tissues
68. Formation of benzo[a]pyrene-DNA adducts by microsomal enzymes: Comparison of maternal and fetal liver, fetal hematopoietic cells and placenta
69. 1 by human placental microsomes
70. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver
71. 1 metabolism
72. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
73. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs
74. Induction of cytochrome P-450c in hematopoietic cells of fetal liver
75. Effects of beta-naphthoflavone and 3-methylcholanthrene administered to pregnant rats on steroid metabolism in the isolated basal zone of the placenta
76. Diet, genetic susceptibility and human cancer etiology
77. 1-epoxide and other substrates
78. Delayed ontogenesis of CYP1A2 in the human liver
79. The developmental expression of alpha-, mu- and pi-class glutathione S-transferases in human liver
80. A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy
81. Embryonic and fetal hemopoiesis: An overview
82. Human liver microsomal epoxide hydrolase: Correlation of immunochemical quantitation with catalytic activity
83. 1 by bacterial recombinant human cytochrome P450 enzymes
84. 1 metabolism as a probe
85. Biochemical toxicology of chemical teratogenesis
86. Field studies of aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma in The Gambia and Thailand
87. Aflatoxin carcinogenesis
88. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3)
89. Identification of a polymorphically expressed member of the human cytochrome P-450III family
90. Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation
91. Functional cytochrome P4503A isoforms in human embryonic tissues: Expression during organogenesis
92. Drug interactions with tobacco smoking: An update